Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta
Clinical trial NCT04945811 · COMPLETED
Trial details
- NCT number
- NCT04945811
- Sponsor
- FARAH AFZAL
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2021-05-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.